The Use of Physiotherapy Navigators in Acute Cancer Care Settings: A Scoping Review
Archives of Rehabilitation Research and Clinical Translation · 2025-09 · 7 (3) · 100489
DOI: 10.1016/j.arrct.2025.100489 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Rehabilitation Research and Clinical Translation, 2025-09. Verfasst von Holly Edward und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: McMaster University, Canadian Institutes of Health Research.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
The objective of this review was to explore and map the use of physiotherapist (PT) navigator roles, their settings, decision-making processes, interventions delivered, barriers, and facilitators in acute cancer care settings. Data Sources: Five databases and gray literature sources were searched to July 4, 2024. Study Selection: To be included in this review, studies must have included adults ≥18 years old living with cancer, used a navigation role or model of care led by a physiotherapist, and occurred in an acute cancer care setting (ie, a setting administering cancer treatments to individuals with a current diagnosis of cancer). Data Extraction: Two independent reviewers completed all screening and data extraction. Data Synthesis: Data were summarized narratively, and descriptive statistics were provided where applicable. Thirteen references were included; 6 perspective papers, 5 research articles, and 2 presentations. The characteristics of PT navigator roles varied but mainly included triaging through assessment (n=13; 100%), exercise planning and prescription (n=9; 69.2%), referral to appropriate services (n=7; 53.8%), barrier identification (n=5; 38.5%), providing education (n=4; 30.8%), and goal setting (n=2; 15.4%). Most PT navigators (n=10; 76.9%) interacted with patients within the first month of treatment and followed up at various timepoints (eg, weekly, monthly, as needed). A range of facilitators (eg, onsite services, support from the medical team, no patient cost to interact with the PT navigator) and barriers (eg, lack of health system funding, lack of medical team knowledge of rehabilitation, and additional patient costs) to the PT navigator role were identified.
Conclusions
This review summarized and mapped the current evidence regarding PT navigation in acute cancer care settings. Future research and clinical programs to enhance the design and implementation of such roles are recommended.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada.
- Oncology, McMaster University, Hamilton, Ontario, Canada.
Förderung
- McMaster University
- Canadian Institutes of Health Research
Zitieren
APA
Edward, H., Paramanantharajah, N., Nannapaneni, N., Wu, J., Wojkowski, S., Macedo, L., Mukherjee, S. D., & Smith-Turchyn, J. (2025). The Use of Physiotherapy Navigators in Acute Cancer Care Settings: A Scoping Review. Archives of Rehabilitation Research and Clinical Translation, 7(3), 100489. https://doi.org/10.1016/j.arrct.2025.100489
Vancouver
Edward H, Paramanantharajah N, Nannapaneni N, Wu J, Wojkowski S, Macedo L, et al. The Use of Physiotherapy Navigators in Acute Cancer Care Settings: A Scoping Review. Archives of Rehabilitation Research and Clinical Translation. 2025;7(3):100489. doi:10.1016/j.arrct.2025.100489
BibTeX
@article{Edward2025,
author = {Edward, Holly and Paramanantharajah, Nelani and Nannapaneni, Neeraja and Wu, Jenette and Wojkowski, Sarah and Macedo, Luciana and Mukherjee, Som D and Smith-Turchyn, Jenna},
title = {The Use of Physiotherapy Navigators in Acute Cancer Care Settings: A Scoping Review},
journal = {Archives of Rehabilitation Research and Clinical Translation},
year = {2025},
volume = {7},
number = {3},
pages = {100489},
doi = {10.1016/j.arrct.2025.100489}
}
EUVIMED